Fundraising Fox
Find your path to Jill
343 people in our graph share verified history with Jill — schools, employers, funds. One of them is your warm intro.
Marcos MillaunlockedJill: together at Synthorx Inc (2019–2021)
Jill: together at elevatebio
Jill: together at Fate Therapeutics
×2Jill: together at Adaptive Biotechnologies
About
Advisor since 2025 with 20 years in synthetic biology and cell and gene therapy, currently CSO of Tregsherpa and CDO of Korsa Therapeutics. She earned her PhD in Immunology from UT Southwestern.
Experience
- Mooney Biotechnology Consulting LLCPresidentcurrent2024 — presentSan Diego, California, United States
- ElevateBioSenior Vice President of Research and Development2022 — 2023Massachusetts, United States
- Synthorx IncHead of Synthorx2021 — 2022San Diego County, California, United States
- Synthorx IncSr. Director of Research2019 — 2021San Diego County, California, United States
- Fate Therapeutics IncDirector of Process Development2017 — 2019San Diego County, California, United States
- Adaptive Biotechnologies Corp.Director of Cell Therapy2017San Diego County, California, United States
- The Janssen Pharmaceutical Companies of Johnson & JohnsonPrincipal Research Scientist2015 — 2017San Diego County, California, United States
- The Janssen Pharmaceutical Companies of Johnson & JohnsonSenior Scientist2012 — 2015San Diego County, California, United States
- Johnson & JohnsonSenior Scientist2010 — 2012San Diego County, California, United States
- Johnson & JohnsonScientist2008 — 2010San Diego County, California, United States
- Johnson & JohnsonPost-doctoral Fellow2006 — 2008
Skills & more
Biologics9Cell Therapy2Life Sciences6Immunology10Biotechnology6Cancer11Flow Cytometry3Molecular Biology4Assay Development2Antibodies2Cell Biology3Cell Based Assays2
+4 more
BiochemistryCell CultureDrug DiscoveryGMP Process DevelopmentFrom Jill's professional profile.
Colleagues at Avalon BioVentures
Abby Beers
FP&A Manager at Avalon BioVentures
Adrienne Terrazas
Executive Admin at Avalon BioVentures
Bryce Suchomel
Advisor at Avalon BioVentures
Christy Sayers
Head of Human Resources at Avalon BioVentures
Eben Massari
Advisor at Avalon BioVentures
Fernando Camejo
Senior Accounting Manager at Avalon BioVentures
Jason Roland
Advisor at Avalon BioVentures
Jay B. Lichter
Managing Partner at Avalon BioVentures
Frequently asked questions
- Who is Jill Mooney?
- Advisor since 2025 with 20 years in synthetic biology and cell and gene therapy, currently CSO of Tregsherpa and CDO of Korsa Therapeutics. She earned her PhD in Immunology from UT Southwestern.
- Where does Jill Mooney work?
- Jill Mooney is Advisor at Avalon BioVentures.
- Where did Jill Mooney go to school?
- Jill Mooney studied at UT Southwestern Medical Center (Ph.D, Immunology); Oregon State University (B.S., Biochemistry and Biophysics).
Same school
Also attended UT Southwestern Medical Center19
Lauren TyraInvestor at Green Park & Golf VenturesHui TianPartner at The Column GroupDeng MaoInvestment Manager at Yonjin Venture LLCOscar MoralezFounder and Managing Partner at Boomerang VenturesUgur EskiocakFounder / EIR at 82VSAbby AlbrightCo-Founder and Investor at WXR Fund
+ 13 more
Also attended Oregon State University118
Mandy CulverInvestor at Next Frontier CapitalElliot HershbergScientist, Writer, and Investor on a mission to accelerate The Century of BiologyPaula MariwalaGeneral Partner Advisor at Beyond Capital VenturesShane WallPartner & President of CXO Network at FusionBrooke PollackManaging Partner at Hutt CapitalMaurice GundersonManaging Director Emeritus at Autotech Ventures
+ 112 more
Shared employers
Also worked at ElevateBio4
Also worked at Synthorx Inc2
Also worked at Fate Therapeutics Inc8
Amir NashatEntrepreneur partner at Polaris Partners focused on healthcare investing and portfolio company executive rolesAndreas NiethammerFounder & Chief Executive Officer at VaximmPratik MultaniChief Medical Officer at ORIC PharmaceuticalsZachary D. HornbyExecutive Officer, Director at Boundless BioEdward DulacExecutive Vice President, Chief Financial Officer at Intellia TherapeuticsNeely MozaffarianChief Medical Officer at Ouro Medicines
+ 2 more
Also worked at Adaptive Biotechnologies Corp.15
Mark AdamsPartner at Two Bear CapitalJan BerkaProject Manager with a Focus on International Contacts at Biotech Investments S.R.OMarcos MillaVenture Partner at Samsara BioCapitalJohn StuelpnagelAdvisor at VenrockHarlan RobinsExecutive Officer at Adaptive BiotechnologiesChad RobinsExecutive Officer, Director at Adaptive Biotechnologies
+ 9 more